Last updated: April 23, 2026
PIRFENIDONE is a branded/marketed name in some jurisdictions, but the dominant global supply landscape is organized around pirfenidone (API) and its validated synthetic intermediates rather than a single proprietary network. The supplier set relevant to commercial manufacturing typically divides into three buckets: (1) API manufacturers, (2) intermediate and custom synthesis providers, and (3) packaging and logistics firms that support GMP distribution.
Who supplies pirfenidone API for commercial procurement?
Below is a supplier map structured for procurement screening. Use it to shortlist potential sources for pirfenidone bulk API and for DMF/CoA alignment workflows.
API manufacturers and GMP-oriented suppliers (screen for DMF/CEP, CoA, and site GMP status)
Common qualifying signals you should verify in the supplier package:
- GMP site manufacturing for pirfenidone (or an established equivalent naming convention)
- Batch documentation readiness (typical CoA items: assay, HPLC purity, water content, residual solvents, heavy metals)
- Regulatory file support: DMF/ASMF availability for pirfenidone
Custom synthesis and intermediate suppliers (screen for route maturity and scale-up capability)
These vendors typically support:
- Key intermediate supply under CMOs/CRO-style agreements
- Scale-up from kg to multi-kg if process control and impurity profile is proven
- Analytical method transfer readiness (HPLC method, impurity panel, stability program support)
Which suppliers handle pirfenidone intermediates and custom routes?
Intermediate vendors are often the fastest path to availability when direct API supply is constrained. Shortlist sources that can provide:
- Intermediates with impurity specifications (not just “reagent grade” materials)
- GMP or GMP-adjacent documentation aligned to API quality expectations
- Process documentation sufficient to run at commercial scale (not pilot-only)
What supplier due-diligence must be completed for PIRFENIDONE?
For pirfenidone procurement, the operational focus should be on quality systems and impurity control, not packaging or freight. Confirm these before placing bulk orders:
Regulatory and quality package
- DMF/ASMF or equivalent regulatory support for pirfenidone
- CoA per lot (assay, impurity profile, water, residual solvents)
- Traceability through raw materials and intermediates
Manufacturing and batch control
- Proven impurity control strategy for the pirfenidone route used by the supplier
- Stability data or commitment to provide stability data under requested conditions
- Residual solvent statements and compliance with pharmacopeial/ICH targets
Contract manufacturing terms that affect delivery risk
- Lead time by batch size
- Allocation clauses for multi-source programs
- Change-control triggers for process or analytical method updates
Supplier categories: how to structure your sourcing decision
| Sourcing goal |
Best supplier category |
What to request |
| Fastest path to bulk API availability |
Intermediate supplier + API manufacturer |
Intermediate specs, impurity panel, then API GMP CoA readiness |
| Long-term multi-year supply |
API manufacturer with regulatory file |
DMF/ASMF, site GMP status, change-control commitments |
| Supply resilience during allocation |
Dual-source approach |
Alternate manufacturer qualification plan and method comparability |
Key Takeaways
- PIRFENIDONE sourcing is typically executed through API manufacturers plus intermediate/custom synthesis providers that support route and impurity control.
- Procurement screening should prioritize DMF/ASMF or equivalent regulatory support, lot-by-lot CoA completeness, and validated impurity control.
- Best practice is a dual-source structure with explicit change-control and lead-time commitments to reduce allocation and batch consistency risk.
FAQs
1) What are the main types of suppliers for pirfenidone?
API manufacturers, intermediate and custom synthesis providers, and GMP distribution partners for logistics and packaging.
2) What documents matter most when buying pirfenidone API?
DMF/ASMF (or equivalent), lot-specific CoA with assay and impurity profile, and GMP manufacturing traceability.
3) Should you buy pirfenidone from an intermediate supplier or an API manufacturer?
For commercial drug manufacturing, the safer route is API manufacturers for direct bulk API. Intermediate suppliers can be used to create resilience or when API supply is constrained.
4) What quality criteria should be checked first?
Impurity profile alignment, residual solvents/water content compliance, and consistency of analytical methods between supplier and manufacturer.
5) How do you reduce procurement and batch consistency risk?
Use at least two qualified sources and require change-control commitments tied to process and analytical method updates.
References
- DrugBank. “Pirfenidone.” https://go.drugbank.com/ (accessed 2026-04-23)
